Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
about
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancerMiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma.Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro studyEpigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signallingMusashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to DaunorubicinClinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast CancerTransformation of the intestinal epithelium by the MSI2 RNA-binding protein.Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathwayMusashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.Plasma fibrinogen level may be a possible marker for the clinical response and prognosis of patients with breast cancer receiving neoadjuvant chemotherapy.RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma.Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.Blast crisis Ph+ chronic myeloid leukemia with NUP98/HOXA13 up-regulating MSI2.Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.Musashi-2 is a prognostic marker for the survival of patients with cervical cancer.Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma.Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
P2860
Q33654184-DF1E5C16-E135-45F1-8F46-7815B9E13962Q33721211-B8BFF778-82EE-42B7-BFEF-7979D0951749Q33756226-87F2DDD8-4CA3-4D93-A344-759E79F333E1Q33802043-45F5349F-EB8A-49ED-B890-E230A36016EAQ34037782-D281FE3A-D9D1-4787-96D3-67525FBAE45EQ34998403-846D9000-8B06-483A-8A64-65E3B5ECB77FQ35666438-6ED2AE9C-D462-42D7-850D-0C5A2F0AB574Q35755864-FC604955-4BAD-4EAB-BDBD-961E06A142C3Q35901137-F50F8280-7C1A-4358-AD8F-9296178FF78FQ36275565-95C15531-78EC-4906-A7C4-4AC608237866Q36797264-1B5C6CB2-F2F5-4E75-B5C6-B7C24E8C086AQ37085883-7EAD6607-0638-4617-905E-541837DD1E55Q37716372-F199C6A4-4B32-49D3-B8CD-461603366072Q38722779-930997DA-1F92-45BE-8F52-C71631AF3A46Q38756835-0B860ADD-18C0-4FD4-B4BD-B355C5B511D3Q38763288-D3AA655D-E690-41FB-A5B1-43DD56441526Q38962280-CA5D8DC5-4DF2-4510-8C02-28D182743CF5Q39112430-8552C91F-47E3-4408-A17B-DDD8E629AD57Q39738967-99D05A56-2E5D-415F-97D9-BC6A71469B08Q41235439-7DBA6EF4-5AF2-4605-8A4E-E278D4993A5BQ41459688-D22CDCD7-7052-4FBF-AF86-B63214D4E1EAQ49658179-ADECB223-09E8-4576-A0BC-454FEB8668E7Q52647714-F4C08681-E6E2-4CF3-B785-84562BEE032AQ52869749-8E0665A8-DFE3-4297-9F7F-B156E61A4ED7Q52903614-DF9D097A-46B8-4338-B8F7-28328B14BC84Q55209640-A2623EF9-7118-4FC2-BF35-754513CB28BAQ55351079-52098BF0-8F46-4CB2-AED8-3525E580D44E
P2860
Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@en
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@nl
type
label
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@en
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@nl
prefLabel
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@en
Musashi2 predicts poor prognos ...... helial-mesenchymal transition.
@nl
P2093
P2860
P356
P1476
Musashi2 predicts poor prognos ...... thelial-mesenchymal transition
@en
P2093
Qiong Zhang
Xinke Zhou
Yunqiang Tang
P2860
P356
10.1111/JCMM.12158
P50
P577
2013-10-31T00:00:00Z